Skip to main content

Blue Owl Capital Holdings LP

13F filer · CIK 0001858703
Reported Aug 11, 2026
Net buyer this quarter
13F portfolio value$665MU.S. long equity reported on 13F
Positions7116 new · 10 closed
Net flow last quarter+$271MBuys minus sells
Top 10 positions weight78.5%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 11, 202671 positions
SPCXSpace Exploration Technologies Corp$239M35.97%Not reportedNewQ2 2026
AKTSAktis Oncology, Inc.$99M14.89%5.74%-2.9%Q1 2026
CGEMCullinan Therapeutics, Inc.$28M4.22%2.39%-19.4%Q4 2023
LRMRLarimar Therapeutics, Inc.$27.9M4.21%8.82%+28.7%Q4 2023
NCDLNuveen Churchill Direct Lending Corp.$26.6M4.01%4.34%Not reportedQ1 2025
MPLTMapLight Therapeutics, Inc.$26.2M3.94%1.61%-27.4%Q1 2026
COFCapital One Financial Corp$24M3.62%0.02%NewQ2 2026
OBDCBlue Owl Capital Corp$22.2M3.35%0.41%Not reportedQ4 2022
FISNDeep Fission, Inc.$14.7M2.22%2.23%NewQ2 2026
DELLDell Technologies Inc.$14.2M2.14%0.01%+137.2%Q4 2021
HLLYHolley Inc.$11.2M1.68%3.64%+3.3%Q1 2025
EYPTEyePoint, Inc.$10.9M1.64%0.90%-16.4%Q1 2025
SGMTSagimet Biosciences Inc.$9.74M1.47%4.11%+277.6%Q4 2023
CRVSCorvus Pharmaceuticals, Inc.$9.09M1.37%0.72%+11.7%Q1 2026
ARTVArtiva Biotherapeutics, Inc.$8.48M1.28%3.54%NewQ2 2026
CMPXCompass Therapeutics, Inc.$7.94M1.19%2.01%+23.2%Q4 2023
CNDTCONDUENT Inc$7.35M1.11%3.24%Not reportedQ1 2025
RYTMRhythm Pharmaceuticals, Inc.$6.82M1.03%0.09%Not reportedQ1 2026
CMPSCOMPASS Pathways plc$6.37M0.96%0.33%Not reportedQ1 2025
RAREUltragenyx Pharmaceutical Inc.$6.1M0.92%0.19%-39.7%Q4 2023
PVLAPalvella Therapeutics, Inc.$5.54M0.83%0.25%+16.0%Q1 2025
IMAImageneBio, Inc.$5.41M0.81%8.14%-4.3%Q3 2025
VRDNViridian Therapeutics, Inc.\DE$4.78M0.72%0.23%NewQ2 2026
IMMXImmix Biopharma, Inc.$4.51M0.68%0.61%-20.1%Q1 2026
ORICOric Pharmaceuticals, Inc.$4.33M0.65%0.39%+166.7%Q1 2026
LENZLENZ Therapeutics, Inc.$4.3M0.65%2.41%+49.3%Q1 2026
AQSTAquestive Therapeutics, Inc.$3.92M0.59%0.75%-30.1%Q1 2024
STWDStarwood Property Trust, Inc.$3.22M0.48%0.05%+23.9%Q4 2021
EVMNEvommune, Inc.$2.39M0.36%0.50%+80.0%Q1 2026
ELDNEledon Pharmaceuticals, Inc.$2.23M0.34%0.70%-60.1%Q1 2025
CABACabaletta Bio, Inc.$2.22M0.33%0.44%Not reportedQ2 2025
CHYMChime Financial, Inc.$1.84M0.28%0.13%NewQ2 2026
CNTXContext Therapeutics Inc.$1.63M0.24%3.19%-42.4%Q2 2024
WWWW International, Inc.$1.35M0.20%0.84%-11.8%Q1 2026
MRKRMarker Therapeutics, Inc.$815K0.12%3.32%Not reportedQ1 2025
ADCTADC Therapeutics SA$785K0.12%0.58%Not reportedQ3 2022
HELPCybin Inc.$396K0.06%0.12%NewQ2 2026
FLDFold Holdings, Inc.$385K0.06%1.56%Not reportedQ2 2025
NIOBWNiocorp Developments Ltd$381K0.06%Not reported-16.2%Q1 2025
RZLVWRezolve Ai PLC$214K0.03%Not reportedNot reportedQ1 2025
BNAIWBrand Engagement Network Inc.$204K0.03%Not reported-12.8%Q1 2025
PIPRPiper Sandler Companies$176K0.03%0.00%Not reportedQ1 2026
ENGNWenGene Therapeutics Inc.$148K0.02%Not reportedNot reportedQ4 2023
CELCCelcuity Inc.$131K0.02%0.00%Not reportedQ2 2024
USDEWStableCoinX Inc.$103K0.02%Not reportedNewQ2 2026
ETEnergy Transfer LP$102K0.02%0.00%Not reportedQ1 2026
CAICaris Life Sciences, Inc.$84K0.01%0.00%Not reportedQ1 2026
VODVodafone Group Public Ltd Co$71K0.01%0.00%NewQ2 2026
DAVEWDave Inc.$68.4K0.01%Not reportedNot reportedQ1 2025
MRNOMurano Global Investments Plc$62.9K0.01%0.33%NewQ2 2026
Q1 2026Reported May 14, 202665 positions
AKTSAktis Oncology, Inc.$56.6M15.20%5.92%NewQ1 2026
LRMRLarimar Therapeutics, Inc.$32M8.61%6.85%Not reportedQ4 2023
ENGNenGene Therapeutics Inc.$30.1M8.08%6.59%Not reportedQ4 2023
NCDLNuveen Churchill Direct Lending Corp.$27.3M7.33%4.34%Not reportedQ1 2025
CGEMCullinan Therapeutics, Inc.$27.1M7.29%3.11%Not reportedQ4 2023
OBDCBlue Owl Capital Corp$22.6M6.08%0.41%Not reportedQ4 2022
MPLTMapLight Therapeutics, Inc.$20.5M5.49%2.23%NewQ1 2026
CMPXCompass Therapeutics, Inc.$15.6M4.18%1.63%Not reportedQ4 2023
CNTXContext Therapeutics Inc.$13.3M3.58%5.54%Not reportedQ2 2024
HLLYHolley Inc.$13M3.49%3.53%Not reportedQ1 2025
EYPTEyePoint, Inc.$11.8M3.16%1.09%Not reportedQ1 2025
CRVSCorvus Pharmaceuticals, Inc.$7.97M2.14%0.65%NewQ1 2026
CNDTCONDUENT Inc$6.45M1.73%3.25%Not reportedQ1 2025
RAREUltragenyx Pharmaceutical Inc.$6.34M1.70%0.31%Not reportedQ4 2023
AQSTAquestive Therapeutics, Inc.$5.59M1.50%1.08%Not reportedQ1 2024
RYTMRhythm Pharmaceuticals, Inc.$5.34M1.44%0.09%NewQ1 2026
IMMXImmix Biopharma, Inc.$4.99M1.34%1.03%NewQ1 2026
IMAImageneBio, Inc.$4.8M1.29%8.58%Not reportedQ3 2025
CVEOCiveo Corp$4.78M1.28%1.65%Not reportedQ1 2025
LENZLENZ Therapeutics, Inc.$4.64M1.25%1.62%NewQ1 2026
ELDNEledon Pharmaceuticals, Inc.$4.37M1.18%1.87%Not reportedQ1 2025
KALVKalVista Pharmaceuticals, Inc.$4.33M1.16%0.42%Not reportedQ3 2025
OVIDOvid Therapeutics Inc.$4.23M1.14%1.14%Not reportedQ4 2023
PVLAPalvella Therapeutics, Inc.$3.9M1.05%0.22%Not reportedQ1 2025
PLRXPliant Therapeutics, Inc.$3.74M1.01%4.80%Not reportedQ4 2023
STWDStarwood Property Trust, Inc.$2.73M0.73%0.04%Not reportedQ4 2021
ADCTADC Therapeutics SA$2.59M0.70%0.58%Not reportedQ3 2022
EVMNEvommune, Inc.$2.3M0.62%0.28%NewQ1 2026
DELLDell Technologies Inc.$2.28M0.61%0.00%Not reportedQ4 2021
ORICOric Pharmaceuticals, Inc.$1.9M0.51%0.14%NewQ1 2026
SGMTSagimet Biosciences Inc.$1.74M0.47%1.09%Not reportedQ4 2023
WWWW International, Inc.$1.31M0.35%0.96%NewQ1 2026
ENGNWenGene Therapeutics Inc.$1.29M0.35%Not reportedNot reportedQ4 2023
EPDEnterprise Products Partners L.P.$1.18M0.32%0.00%Not reportedQ1 2025
FLDFold Holdings, Inc.$1.13M0.30%1.70%Not reportedQ2 2025
OPTXWSyntec Optics Holdings, Inc.$867K0.23%Not reportedNot reportedQ1 2025
MRKRMarker Therapeutics, Inc.$721K0.19%3.32%Not reportedQ1 2025
NIOBWNiocorp Developments Ltd$525K0.14%Not reportedNot reportedQ1 2025
BNAIWBrand Engagement Network Inc.$417K0.11%Not reportedNot reportedQ1 2025
CAHCardinal Health Inc$363K0.10%0.00%Not reportedQ1 2025
RZLVWRezolve Ai PLC$202K0.05%Not reportedNot reportedQ1 2025
PIPRPiper Sandler Companies$186K0.05%0.00%NewQ1 2026
AMODAlpha Modus Holdings, Inc.$146K0.04%0.77%Not reportedQ1 2025
ETEnergy Transfer LP$103K0.03%0.00%NewQ1 2026
DAICCID Holdco, Inc.$94.8K0.03%1.88%NewQ1 2026
CAICaris Life Sciences, Inc.$84.2K0.02%0.00%NewQ1 2026
AMODWAlpha Modus Holdings, Inc.$74.2K0.02%Not reportedNot reportedQ1 2025
SHFSSHF Holdings, Inc.$63K0.02%1.77%Not reportedQ1 2025
GOCOGoHealth, Inc.$61.6K0.02%4077.00%Not reportedQ4 2021
AEONAEON Biopharma, Inc.$41.5K0.01%0.17%Not reportedQ1 2025
Q3 2025Reported Nov 12, 202569 positions
NCDLNuveen Churchill Direct Lending Corp.$42.7M13.24%6.26%-23.5%Q1 2025
OBDCBlue Owl Capital Corp$26.1M8.11%0.40%Not reportedQ4 2022
ENGNenGene Therapeutics Inc.$22.4M6.95%6.40%-12.1%Q4 2023
LRMRLarimar Therapeutics, Inc.$18.9M5.87%6.84%+18.8%Q4 2023
EVCMEverCommerce Inc.$18.3M5.67%0.91%Not reportedQ1 2024
HLLYHolley Inc.$15.3M4.74%4.07%+18.2%Q1 2025
ROIVRoivant Sciences Ltd.$15M4.64%0.14%Not reportedQ1 2025
CGEMCullinan Therapeutics, Inc.$14.9M4.62%4.25%+5.2%Q4 2023
RAREUltragenyx Pharmaceutical Inc.$12.7M3.94%0.44%+65.5%Q4 2023
CNDTCONDUENT Inc$12.5M3.87%2.88%Not reportedQ1 2025
SGMTSagimet Biosciences Inc.$9.11M2.83%4.33%Not reportedQ4 2023
CMPXCompass Therapeutics, Inc.$9.07M2.82%1.46%Not reportedQ4 2023
DELLDell Technologies Inc.$7.42M2.30%0.01%+151.0%Q4 2021
CVEOCiveo Corp$7.3M2.27%2.73%Not reportedQ1 2025
CNTXContext Therapeutics Inc.$7.18M2.23%8.06%Not reportedQ2 2024
AQSTAquestive Therapeutics, Inc.$6.99M2.17%1.03%+35.9%Q1 2024
IRONDisc Medicine, Inc.$6.76M2.10%0.29%-16.4%Q4 2023
RPTXRepare Therapeutics Inc.$6.06M1.88%8.01%Not reportedQ4 2023
PVLAPalvella Therapeutics, Inc.$5.97M1.85%0.86%-24.0%Q1 2025
EYPTEyePoint, Inc.$5.23M1.62%0.53%-34.7%Q1 2025
KRROKorro Bio, Inc.$5.03M1.56%1.12%-16.0%Q2 2025
IMAImageneBio, Inc.$4.41M1.37%13.45%NewQ3 2025
PLRXPliant Therapeutics, Inc.$4.39M1.36%4.83%Not reportedQ4 2023
CNTACentessa Pharmaceuticals PLC$4.11M1.28%0.13%-48.7%Q1 2025
IMRXImmuneering Corp$3.85M1.20%2.12%NewQ3 2025
MLYSMineralys Therapeutics, Inc.$3.83M1.19%0.13%-70.0%Q4 2023
CMPSCOMPASS Pathways plc$3.47M1.08%0.63%+163.1%Q1 2025
ADCTADC Therapeutics SA$2.93M0.91%0.65%Not reportedQ3 2022
NUNu Holdings Ltd.$2.78M0.86%Not reportedNot reportedQ2 2022
MREOMereo BioPharma Group plc$2.58M0.80%0.16%Not reportedQ2 2024
ELDNEledon Pharmaceuticals, Inc.$2.54M0.79%1.64%-26.3%Q1 2025
ACLXArcellx, Inc.$2.2M0.68%0.05%Not reportedQ4 2022
KALVKalVista Pharmaceuticals, Inc.$1.52M0.47%0.25%NewQ3 2025
FLDFold Holdings, Inc.$1.45M0.45%1.78%Not reportedQ2 2025
NIOBWNiocorp Developments Ltd$1.01M0.31%Not reportedNot reportedQ1 2025
TNGXTango Therapeutics, Inc.$1M0.31%0.11%-85.3%Q1 2025
EPDEnterprise Products Partners L.P.$978K0.30%0.00%Not reportedQ1 2025
GTLBGitlab Inc.$557K0.17%Not reportedNot reportedQ1 2023
SHFSSHF Holdings, Inc.$543K0.17%2.60%Not reportedQ1 2025
TTANServiceTitan, Inc.$500K0.16%0.01%-56.4%Q2 2025
MRKRMarker Therapeutics, Inc.$495K0.15%3.32%Not reportedQ1 2025
RZLVWRezolve Ai PLC$470K0.15%Not reported-38.6%Q1 2025
AMODAlpha Modus Holdings, Inc.$454K0.14%0.94%Not reportedQ1 2025
CAHCardinal Health Inc$270K0.08%0.00%Not reportedQ1 2025
PJCPiper Sandler Companies$211K0.07%Not reportedNewQ3 2025
SLNDSouthland Holdings, Inc.$166K0.05%1.59%Not reportedQ1 2025
AMODWAlpha Modus Holdings, Inc.$144K0.04%Not reportedNot reportedQ1 2025
BGLWWBlue Gold Ltd$80.1K0.02%Not reportedNot reportedQ2 2025
OPTXWSyntec Optics Holdings, Inc.$70K0.02%Not reportedNot reportedQ1 2025
BKSYWBlackSky Technology Inc.$59K0.02%Not reportedNot reportedQ1 2025
Q2 2025Reported Aug 11, 202568 positions
NCDLNuveen Churchill Direct Lending Corp.$65.4M21.11%8.15%Not reportedQ1 2025
OBDCBlue Owl Capital Corp$29.3M9.46%0.40%Not reportedQ4 2022
CGEMCullinan Therapeutics, Inc.$18M5.80%4.04%-2.1%Q4 2023
EVCMEverCommerce Inc.$17.2M5.56%0.90%Not reportedQ1 2024
TRMLTourmaline Bio, Inc.$15.9M5.15%3.88%-3.9%Q4 2023
LRMRLarimar Therapeutics, Inc.$14.2M4.60%7.70%+3.1%Q4 2023
ENGNenGene Therapeutics Inc.$13.6M4.38%7.30%+13.7%Q4 2023
CNDTCONDUENT Inc$11.8M3.80%2.80%-21.8%Q1 2025
SGMTSagimet Biosciences Inc.$10.1M3.27%4.33%Not reportedQ4 2023
RAREUltragenyx Pharmaceutical Inc.$9.28M3.00%0.26%+66.6%Q4 2023
HLLYHolley Inc.$8.22M2.65%3.44%-22.7%Q1 2025
CVEOCiveo Corp$7.33M2.37%2.50%-8.9%Q1 2025
CMPXCompass Therapeutics, Inc.$6.74M2.17%1.87%-12.3%Q4 2023
IRONDisc Medicine, Inc.$6.47M2.09%0.35%-12.8%Q4 2023
EYPTEyePoint, Inc.$5.29M1.71%0.82%-29.5%Q1 2025
TEMTempus AI, Inc.$5.09M1.64%Not reportedNewQ2 2025
CNTXContext Therapeutics Inc.$4.85M1.57%8.26%+0.5%Q2 2024
RPTXRepare Therapeutics Inc.$4.79M1.54%8.02%Not reportedQ4 2023
MLYSMineralys Therapeutics, Inc.$4.55M1.47%0.51%+62.9%Q4 2023
CNTACentessa Pharmaceuticals PLC$4.34M1.40%0.25%+5.0%Q1 2025
TNGXTango Therapeutics, Inc.$4.17M1.35%0.73%-61.6%Q1 2025
ELDNEledon Pharmaceuticals, Inc.$3.6M1.16%2.22%-26.9%Q1 2025
PLRXPliant Therapeutics, Inc.$3.44M1.11%4.84%Not reportedQ4 2023
AQSTAquestive Therapeutics, Inc.$3.05M0.98%0.93%Not reportedQ1 2024
PVLAPalvella Therapeutics, Inc.$2.82M0.91%1.13%-10.7%Q1 2025
STWDStarwood Property Trust, Inc.$2.64M0.85%0.04%Not reportedQ4 2021
DELLDell Technologies Inc.$2.56M0.82%0.00%Not reportedQ4 2021
BMEABiomea Fusion, Inc.$2.34M0.76%2.24%NewQ2 2025
ADCTADC Therapeutics SA$1.97M0.63%0.65%Not reportedQ3 2022
FLDFold Holdings, Inc.$1.92M0.62%1.84%NewQ2 2025
VRNAVerona Pharma plc$1.74M0.56%0.00%Not reportedQ1 2025
CABACabaletta Bio, Inc.$1.71M0.55%1.23%NewQ2 2025
KRROKorro Bio, Inc.$1.56M0.50%1.33%NewQ2 2025
APGEApogee Therapeutics, Inc.$1.52M0.49%0.06%NewQ2 2025
TTANServiceTitan, Inc.$1.22M0.39%0.03%NewQ2 2025
EPDEnterprise Products Partners L.P.$970K0.31%0.00%Not reportedQ1 2025
MRKRMarker Therapeutics, Inc.$848K0.27%4.90%Not reportedQ1 2025
CMPSCOMPASS Pathways plc$644K0.21%0.25%-79.8%Q1 2025
RZLVRezolve Ai PLC$559K0.18%0.09%Not reportedQ1 2025
AMODAlpha Modus Holdings, Inc.$418K0.13%0.97%Not reportedQ1 2025
RZLVWRezolve Ai PLC$381K0.12%Not reported-21.0%Q1 2025
SLNDSouthland Holdings, Inc.$294K0.09%1.59%Not reportedQ1 2025
CAHCardinal Health Inc$289K0.09%0.00%Not reportedQ1 2025
NIOBWNiocorp Developments Ltd$277K0.09%Not reported-28.7%Q1 2025
AMODWAlpha Modus Holdings, Inc.$202K0.07%Not reportedNot reportedQ1 2025
SHFSSHF Holdings, Inc.$165K0.05%2.69%Not reportedQ1 2025
BKSYWBlackSky Technology Inc.$103K0.03%Not reportedNot reportedQ1 2025
OPTXWSyntec Optics Holdings, Inc.$69.8K0.02%Not reportedNot reportedQ1 2025
DAVEWDave Inc.$52K0.02%Not reportedNot reportedQ1 2025
BNAIWBrand Engagement Network Inc.$50.2K0.02%Not reportedNot reportedQ1 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.